78 related articles for article (PubMed ID: 20518747)
1. Association of putative functional variants in the PLAU gene and the PLAUR gene with myocardial infarction.
Xu J; Li W; Bao X; Ding H; Chen J; Zhang W; Sun K; Wang J; Wang X; Wang H; Yu H; Song W; Ma W; Zhang L; Wang C; Wang D; Hui R
Clin Sci (Lond); 2010 Jul; 119(8):353-9. PubMed ID: 20518747
[TBL] [Abstract][Full Text] [Related]
2. Association study of ACE2 (angiotensin I-converting enzyme 2) gene polymorphisms with coronary heart disease and myocardial infarction in a Chinese Han population.
Yang W; Huang W; Su S; Li B; Zhao W; Chen S; Gu D
Clin Sci (Lond); 2006 Nov; 111(5):333-40. PubMed ID: 16822235
[TBL] [Abstract][Full Text] [Related]
3. A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease.
Riemenschneider M; Konta L; Friedrich P; Schwarz S; Taddei K; Neff F; Padovani A; Kölsch H; Laws SM; Klopp N; Bickeböller H; Wagenpfeil S; Mueller JC; Rosenberger A; Diehl-Schmid J; Archetti S; Lautenschlager N; Borroni B; Müller U; Illig T; Heun R; Egensperger R; Schlegel J; Förstl H; Martins RN; Kurz A
Hum Mol Genet; 2006 Aug; 15(16):2446-56. PubMed ID: 16825285
[TBL] [Abstract][Full Text] [Related]
4. The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-epsilon4 non-carriers in the Italian Alzheimer's disease population and does not affect the plasma Abeta(1-42) level.
Pesaresi M; Batelli S; Prato F; Polito L; Lovati C; Scarpini E; Quadri P; Mariani C; Albani D; Forloni G
Neurobiol Dis; 2007 Mar; 25(3):609-13. PubMed ID: 17174555
[TBL] [Abstract][Full Text] [Related]
5. Variants in the coagulation factor 2 receptor (F2R) gene influence the risk of myocardial infarction in men through an interaction with interleukin 6 serum levels.
Gigante B; Vikström M; Meuzelaar LS; Chernogubova E; Silveira A; Hooft FV; Hamsten A; de Faire U
Thromb Haemost; 2009 May; 101(5):943-53. PubMed ID: 19404549
[TBL] [Abstract][Full Text] [Related]
6. Epistatic interaction between haplotypes of the ghrelin ligand and receptor genes influence susceptibility to myocardial infarction and coronary artery disease.
Baessler A; Fischer M; Mayer B; Koehler M; Wiedmann S; Stark K; Doering A; Erdmann J; Riegger G; Schunkert H; Kwitek AE; Hengstenberg C
Hum Mol Genet; 2007 Apr; 16(8):887-99. PubMed ID: 17324965
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of plasma urokinase-type plasminogen activator and urokinase-type plasminogen-activator receptor in patients with acute and chronic hepatitis B.
Zhou H; Wu X; Lu X; Chen G; Ye X; Huang J
Thromb Res; 2009; 123(3):537-42. PubMed ID: 18691743
[TBL] [Abstract][Full Text] [Related]
8. Urinary levels of urokinase-type plasminogen activator and its receptor in the detection of bladder carcinoma.
Casella R; Shariat SF; Monoski MA; Lerner SP
Cancer; 2002 Dec; 95(12):2494-9. PubMed ID: 12467062
[TBL] [Abstract][Full Text] [Related]
9. Significant association of urokinase plasminogen activator Pro141Leu with serum lipid profiles in a Japanese population.
Tamura T; Morita E; Kawai S; Okada R; Naito M; Wakai K; Hori Y; Kondo T; Hamajima N
Gene; 2013 Jul; 524(2):363-7. PubMed ID: 23628797
[TBL] [Abstract][Full Text] [Related]
10. Common polymorphisms in the cannabinoid CB2 receptor gene (CNR2) are not associated with myocardial infarction and cardiovascular risk factors.
Reinhard W; Stark K; Neureuther K; Sedlacek K; Fischer M; Baessler A; Weber S; Kaess B; Wiedmann S; Erdmann J; Lieb W; Jeron A; Riegger G; Hengstenberg C
Int J Mol Med; 2008 Aug; 22(2):165-74. PubMed ID: 18636169
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
[TBL] [Abstract][Full Text] [Related]
12. [Expression of urokinase-type plasminogen activator and its receptor in plasma of patients with cerebral infarction].
Song SJ; Hu JB; Wang HX; Wen SQ; Ding MP; Huang JZ
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(18):1583-5. PubMed ID: 14642114
[TBL] [Abstract][Full Text] [Related]
13. The common Y402H variant in complement factor H gene is not associated with susceptibility to myocardial infarction and its related risk factors.
Stark K; Neureuther K; Sedlacek K; Hengstenberg W; Fischer M; Baessler A; Wiedmann S; Jeron A; Holmer S; Erdmann J; Schunkert H; Hengstenberg C
Clin Sci (Lond); 2007 Aug; 113(4):213-8. PubMed ID: 17472578
[TBL] [Abstract][Full Text] [Related]
14. 5-Hydroxytryptamine 5-HT2A receptor and 5-hydroxytryptamine transporter polymorphisms in acute myocardial infarction.
Coto E; Reguero JR; Alvarez V; Morales B; Batalla A; González P; Martín M; García-Castro M; Iglesias-Cubero G; Cortina A
Clin Sci (Lond); 2003 Mar; 104(3):241-5. PubMed ID: 12605580
[TBL] [Abstract][Full Text] [Related]
15. Haplotype analysis of the CYP8A1 gene associated with myocardial infarction.
Xiang Xie ; Ma YT; Fu ZY; Yang YN; Xiang Ma ; Chen BD; Wang YH; Fen Liu
Clin Appl Thromb Hemost; 2009 Oct; 15(5):574-80. PubMed ID: 19147528
[TBL] [Abstract][Full Text] [Related]
16. Association between PPARalpha gene polymorphisms and myocardial infarction.
Reinhard W; Stark K; Sedlacek K; Fischer M; Baessler A; Neureuther K; Weber S; Kaess B; Wiedmann S; Mitsching S; Lieb W; Erdmann J; Meisinger C; Doering A; Tolle R; Jeron A; Riegger G; Hengstenberg C
Clin Sci (Lond); 2008 Nov; 115(10):301-8. PubMed ID: 18336366
[TBL] [Abstract][Full Text] [Related]
17. Genotypes and haplotypes predisposing to myocardial infarction: a multilocus case-control study.
Tobin MD; Braund PS; Burton PR; Thompson JR; Steeds R; Channer K; Cheng S; Lindpaintner K; Samani NJ
Eur Heart J; 2004 Mar; 25(6):459-67. PubMed ID: 15039125
[TBL] [Abstract][Full Text] [Related]
18. Tissue-type plasminogen activator -7,351C/T enhancer polymorphism is associated with a first myocardial infarction.
Ladenvall P; Johansson L; Jansson JH; Jern S; Nilsson TK; Tjärnlund A; Jern C; Boman K
Thromb Haemost; 2002 Jan; 87(1):105-9. PubMed ID: 11848437
[TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of the genes encoding urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in advanced ovarian cancer.
Türkmen B; Schmitt M; Schmalfeldt B; Trommler P; Hell W; Creutzburg S; Graeff H; Magdolen V
Electrophoresis; 1997 May; 18(5):686-9. PubMed ID: 9194591
[TBL] [Abstract][Full Text] [Related]
20. Distribution of tissue plasminogen activator insertion/deletion polymorphism in myocardial infarction and control subjects.
Steeds R; Adams M; Smith P; Channer K; Samani NJ
Thromb Haemost; 1998 May; 79(5):980-4. PubMed ID: 9609233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
